Metraipolis › archive › dc_0631e162bfc9

SLC16A3 drives lung adenocarcinoma progression and gefitinib resistance through coordinated regulation of ferroptosis and lactate metabolism — Europe PMC PMID:41293164

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41293164
DOI
10.3389/fimmu.2025.1699540
License (as archived)
solo-consultazione
Archived
2026-11-08T17:03:58.905Z
SHA-256 of the archived text
47da9e7cb00324ac3656c295443eb4fa6b1838e79d6782991210fe1e2e5adc35
Stable URL of this page
https://metraipolis.com/documento/dc_0631e162bfc9

How to cite

SLC16A3 drives lung adenocarcinoma progression and gefitinib resistance through coordinated regulation of ferroptosis and lactate metabolism — Europe PMC PMID:41293164 — Europe PMC (en), https://europepmc.org/article/MED/41293164 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0631e162bfc9 (Metraipolis archive dc_0631e162bfc9, sha256 47da9e7cb00324ac3656c295443eb4fa6b1838e79d6782991210fe1e2e5adc35)
BibTeX
@misc{dc0631e162bfc9,
  title = {SLC16A3 drives lung adenocarcinoma progression and gefitinib resistance through coordinated regulation of ferroptosis and lactate metabolism — Europe PMC PMID:41293164},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41293164},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0631e162bfc9; sha256 47da9e7cb00324ac3656c295443eb4fa6b1838e79d6782991210fe1e2e5adc35},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41293164. Agents can read the archived copy with the MCP tool read_document.